About Multiple System Atrophy (MSA, Shy-Drager Syndrome)

Overview
Multiple System Atrophy (MSA) or Shy-Drager syndrome, is a progressive neurodegenerative disorder that affects both the central nervous system (which controls movement) and the autonomic nervous system (which controls involuntary functions like blood pressure and digestion). It is characterized by the loss of different types of nerve cells in the brain and spinal cord. The initial symptoms of MSA can be similar to those of Parkinson's disease, including slowness of movement, tremor, stiffness, lack of coordination, and changes in voice. As the disease progresses, individuals with MSA may experience difficulty with movement and eventually become bedridden. Swallowing problems can also develop, which may lead to pneumonia in later stages. MSA typically appears in a person's 50s and progresses rapidly over five to 10 years.
Causes and Risk Factors

The cause of MSA is still not fully understood. Proposed causes of MSA include:

  • Accumulation of alpha-synuclein protein in the brain, which leads to the degeneration and death of neurons.
  • Disruption of functional connectivity among specific brain regions that may contribute to the clinical symptoms of MSA.
  • Oxidative stress may worsen or trigger MSA

Non-modifiable risk factors are factors that cannot be changed or controlled. These include:

  • Genetic factors: Changes in certain genes, such as SNCA and COQ2, have been associated with an increased risk of MSA. Variations in these genes may affect the production and function of proteins involved in brain cell function.

It's important to note that these proposed causes and risk factors are based on current research and understanding. However, more research is needed to fully comprehend the underlying mechanisms and identify additional risk factors for MSA.

Symptoms

The most common early symptoms of MSA include:

  • Tremors
  • Muscle stiffness
  • Lack of coordination
  • Difficulty controlling urination
  • Erectile dysfunction
  • A sudden drop in blood pressure upon standing

As MSA progresses or reaches higher severity, additional symptoms may occur, such as:

  • Speech difficulties or a quivering voice.
  • Problems with coordination and balance
  • Fainting
  • Clumsiness

It's important to note that MSA is a progressive condition, and symptoms generally worsen over time. Treatment options are available to manage symptoms, but it's crucial to consult with a healthcare professional for proper evaluation and guidance.

Diagnosis

To diagnose MSA, healthcare providers typically perform a combination of examinations, tests, and procedures. These may include:

  • Physical exam: The healthcare provider will conduct a physical exam to look for physical signs of a medical problem, such as pain, swelling, or masses within the body.
  • Medical history: The healthcare provider will gather information about your medical history and family history to understand your symptoms better.
  • Neurological examination: A comprehensive neurological examination will be conducted to assess motor skills, reflexes, coordination, and sensory function.
  • Autonomic testing: This involves assessing autonomic functions such as blood pressure and heart rate control.
  • Bladder function assessment: The healthcare provider may evaluate bladder function to identify any abnormalities.
  • Brain imaging: Magnetic Resonance Imaging (MRI) or Positron Emission Tomography (PET) scans may be ordered to detect changes in the brain that suggest MSA or rule out other causes of similar symptoms.
  • Dopamine transporter (DaT) scans: These scans can assess the distribution and activity of dopamine in the brain and help differentiate MSA from Parkinson's disease.

To determine the stage or severity of MSA, additional examinations or assessments may include:

  • Clinical rating scales: Healthcare providers may use rating scales like the Unified Parkinson's Disease Rating Scale (UPDRS) to assess motor function and disease progression.
  • Neuropsychological assessment: This evaluation helps assess cognitive function and detect any changes in thinking, memory, or behavior associated with MSA.

It's important to note that these examinations, tests, and procedures are typically performed by healthcare professionals and require a referral from your primary care provider. It's recommended to consult with your doctor for personalized advice regarding your individual situation.

Treatment Options

The goals of treatment for MSA are to manage symptoms, improve quality of life, and slow down disease progression. Here are some treatment options:

  • Medication types:
    • Dopamine agonist: To help improve motor function, but the benefits are often short-lived
    • Botulinum toxin injections can ease abnormal muscle postures.
    • Medications to manage blood pressure
    • Medications for bladder control and sleep problems
  • Therapies and therapeutic procedures:
    • Physical therapy
    • Speech therapy
    • Feeding tube or nutritional support
    • Compression stockings or abdominal binder
  • Health behavior changes:
    • Increasing water intake and adding extra salt to the diet can help manage orthostatic hypotension.
    • Avoiding heavy meals

It's important to note that the effectiveness of these treatments may vary from person to person. Treatment decisions should be individualized based on patient characteristics, goals, and concerns. Before starting any new treatments consult with a healthcare professional for appropriate medication dosing and potential side effect information.

Medication dosing may be affected by many factors. Check with your health care professional about dosing for your individual situation. Other side effects can occur. Check with your health care professional or read the information provided with your medication for additional side effect information.